Fractyl Health, Inc. Common Stock(GUTS)
Biotechnology
Gene Therapy & Gene Editing
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | Royan Ajay Director | Purchase | +23,000 | +128.48%40,901 | $0.85 | $19,596 | View SEC filing | |
| 2026-06-11 | BRADLEY WILLIAM Director | Purchase | +68,493 | +424.66%84,622 | $0.73 | $50,329 | View SEC filing | |
| 2026-06-11 | Sheffield Ian Director | Purchase | +35,000 | +100.00%35,000 | $0.73 | $25,529 | View SEC filing | |
| 2026-06-11 | Rajagopalan Harith Chief Executive Officer | Purchase | +25,000 | +4.85%540,557 | $0.73 | $18,253 | View SEC filing | |
| 2026-06-09 | Smith Weber Lara Chief Financial Officer | Purchase | +20,000 | +100.00%20,000 | $0.69 | $13,708 | View SEC filing | |
| 2025-12-08 | Rajagopalan Harith Chief Executive Officer | Purchase | +10,416 | +2.12%501,745 | $1.92 | $19,999 | View SEC filing | |
| 2025-03-18 | Royan Ajay Director, 10% Owner | Purchase | +17,901 | +100.00%17,901 | $1.28 | $22,980 | View SEC filing | |
| 2025-03-18 | Barnes Kelly Ann Director | Purchase | +31,000 | +100.00%31,000 | $1.30 | $40,210 | View SEC filing | |
| 2025-03-17 | SCHULMAN AMY W Director | Purchase | +8,550 | +100.00%8,550 | $1.17 | $9,964 | View SEC filing | |
| 2025-03-17 | BRADLEY WILLIAM Director | Purchase | +16,129 | +100.00%16,129 | $1.26 | $20,358 | View SEC filing | |
| 2025-03-17 | Conaway Samuel Director | Purchase | +8,550 | +100.00%8,550 | $1.17 | $9,964 | View SEC filing | |
| 2025-02-03 | Rajagopalan Harith Chief Executive Officer | Sale | -111,920 | -4.09%491,329 | $1.84 | $206,003 | View SEC filing | |
| 2025-02-03 | Caplan Jay David President, Chief Product Off. | Sale | -43,818 | -12.27%153,544 | $1.88 | $82,266 | View SEC filing | |
| 2024-11-13 | Rajagopalan Harith Chief Executive Officer | Sale | -96,517 | -16.42%491,329 | $2.47 | $238,358 | View SEC filing | |
| 2024-11-13 | Caplan Jay David President, Chief Product Off. | Sale | -64,197 | -29.48%153,544 | $2.47 | $158,541 | View SEC filing | |
| 2024-09-13 | Caplan Jay David President, Chief Product Off. | Sale | -65,000 | -68.07%30,484 | $2.90 | $188,474 | View SEC filing | |
| 2024-02-08 | Royan Ajay Director, 10% Owner | Purchase | +333,333 | +36.29%1,251,900 | $15.00 | $4,999,995 | View SEC filing | |
| 2024-02-08 | THIEL PETER 10% Owner | Purchase | +333,333 | +36.29%1,251,900 | $15.00 | $4,999,995 | View SEC filing | |
| 2024-02-08 | M28 Capital Management LP Director | Purchase | +466,666 | +33.59%1,856,117 | $15.00 | $6,999,990 | View SEC filing | |
| 2024-02-06 | CVF, LLC 10% Owner | Purchase | +333,333 | +7.68%4,673,870 | $15.00 | $4,999,995 | View SEC filing |
1-20 of 20